Focal One® Robotic HIFU System
Prostate Tissue Ablation (Primary use: Localized Prostate Cancer)
CommercialActive
Key Facts
Indication
Prostate Tissue Ablation (Primary use: Localized Prostate Cancer)
Phase
Commercial
Status
Active
Company
About FocalOne
Focal One is a commercial-stage medical device company focused on revolutionizing prostate cancer therapy through its robotic focal HIFU platform. Its flagship Focal One® system offers a non-invasive, non-surgical, and non-radiation alternative for targeted prostate tissue ablation, positioned between active surveillance and radical therapies. The company is actively building its commercial footprint, supported by clinical evidence and partnerships with leading medical institutions, targeting a significant gap in the prostate cancer management continuum.
View full company profile